HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021
Corporate Participants:
Jennifer Smith — Director, Investor Relations
Scott Cooper — President, Chief Executive Officer and Director
Trent MacDonald — Chief Financial Officer
Valerie Malone — Chief Commercial Officer
Analysts:
Aaron Grey — Alliance Global Partners — Analyst
Rupesh Parikh — Oppenheimer — Analyst
Tamy Chen — BMO Capital Markets — Analyst
Douglas Miehm — RBC Capital Markets — Analyst
John Zamparo — CIBC — Analyst
Adam Buckham — Scotiabank — Analyst
———-
To read the full earnings call transcript, click here
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Listen On
